| 000 | 01665 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518045324.0 | ||
| 264 | 0 | _c20191202 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1557-9034 | ||
| 024 | 7 |
_a10.1089/lap.2019.0350 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDi Corpo, Marco | |
| 245 | 0 | 0 |
_aTreatment Modalities for Esophageal Adenocarcinoma in the United States: Trends and Survival Outcomes. _h[electronic resource] |
| 260 |
_bJournal of laparoendoscopic & advanced surgical techniques. Part A _cAug 2019 |
||
| 300 |
_a989-994 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xepidemiology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aChemoradiotherapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aEsophageal Neoplasms _xepidemiology |
| 650 | 0 | 4 | _aEsophagectomy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 | _aPoisson Distribution |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 | _aSEER Program |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aSchlottmann, Francisco | |
| 700 | 1 | _aStrassle, Paula D | |
| 700 | 1 | _aNurczyk, Kamil | |
| 700 | 1 | _aPatti, Marco G | |
| 773 | 0 |
_tJournal of laparoendoscopic & advanced surgical techniques. Part A _gvol. 29 _gno. 8 _gp. 989-994 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/lap.2019.0350 _zAvailable from publisher's website |
| 999 |
_c29843127 _d29843127 |
||